DOI:
10.1055/s-00035331
Revista Urología Colombiana / Colombian Urology Journal
LinksClose Window
References
Sartor AO, Morris MJ, Krause BJ.
VISION: An international, prospective, open-label, multicenter, randomized phase 3 study of 177Lu-PSMA-617 in the treatment of patients with progressive PSMA-positive metastatic castration-resistant prostate cancer (mCRPC).
J Clin Oncol 2019;
37 (15_suppl): TPS5099-TPS5099 [Internet] 10.1200/JCO.2019.37.15_suppl.TPS5099
We do not assume any responsibility for the contents of the web pages of other providers.